SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: TNBC|Brain Metastasis
Interventions: DRUG: SHR-A1921 + Bevacizumab
Sponsor: Fudan University